Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bolus Interleukin-2 in Previously Treated Lung Cancer
NCT00003090Phase 2Unknown
- Sponsor
- Cancer Biotherapy Research Group
- Start
- Jan 1996
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of aldesleukin in non-small cell lung cancer (NSCLC), sponsored by Cancer Biotherapy Research Group. Status: unknown.
02
Drugs
aldesleukin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00003090.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003090.